Apic Bio Launches to Advance First-in-Class Gene Therapy for Treatment of Alpha-1 Antitrypsin Deficiency (Alpha 1)Business Wire (press release)CAMBRIDGE, Mass.–(BUSINESS WIRE)–Apic Bio, Inc., a pre-clinical stage gene therapy company leveraging its p… Continue reading
Press Telegraph |
CRISPR Therapeutics, MGH Partner to Develop T–Cell Cancer Therapies
Genetic Engineering & Biotechnology News CRISPR Therapeutics’ interest in next-generation T–Cell cancer immunotherapies comes as both Kite Pharma and Novartis await FDA decisions on their CAR-T immuno-oncology treatments, with the companies emerging as leading developers of CAR-T … Building up its I/O ops, CRISPR Therapeutics allies with Marcela Maus at Mass GeneralEndpoints News CRISPR Therapeutics Announces Collaboration with Massachusetts General Hospital to Research Use of CRISPR …GlobeNewswire (press release) |
Press Telegraph |
CRISPR Therapeutics, MGH Partner to Develop T–Cell Cancer Therapies
Genetic Engineering & Biotechnology News CRISPR Therapeutics’ interest in next-generation T–Cell cancer immunotherapies comes as both Kite Pharma and Novartis await FDA decisions on their CAR-T immuno-oncology treatments, with the companies emerging as leading developers of CAR-T … Building up its I/O ops, CRISPR Therapeutics allies with Marcela Maus at Mass GeneralEndpoints News CRISPR Therapeutics Announces Collaboration with Massachusetts General Hospital to Research Use of CRISPR …GlobeNewswire (press release) |
Insider Financial |
US Stem Cell Inc (OTCMKTS:USRM): Buy The Science
Insider Financial Regular readers will know that US Stem Cell Inc (OTCMKTS:USRM) is one of the companies we keep coming back to here at Insider Financial. It’s a biotech play that, as outlined in previous coverage, we feel is undervalued at current prices and we think … |
Insider Financial |
US Stem Cell Inc (OTCMKTS:USRM): Buy The Science
Insider Financial Regular readers will know that US Stem Cell Inc (OTCMKTS:USRM) is one of the companies we keep coming back to here at Insider Financial. It’s a biotech play that, as outlined in previous coverage, we feel is undervalued at current prices and we think … |
The Guardian |
Space savers: astronaut urine could make supplies from nutrients to tools
The Guardian “Capabilities in synthetic biology enable us to create different strains of yeast that can make a variety of different products,” said Blenner, adding that the yeast itself takes up very little space and is low-mass. While astronauts have previously … Turning human waste into plastic, nutrients could aid long-distance space travelGears Of Biz |
Endpoints News |
Building up its I/O ops, CRISPR Therapeutics allies with Marcela Maus at Mass General
Endpoints News CRISPR Therapeutics $CRSP is allying with some top immuno-oncology researchers at Mass General to collaborate on some new gene editing working aimed at creating a new and better generation of T cell therapies. The biotech — based in Switzerland … CRISPR Therapeutics Announces Collaboration with Massachusetts General Hospital to Research Use of CRISPR …GlobeNewswire (press release) It Seems Crispr Therapeutics AG (NASDAQ:CRSP) Will Go Down. Just Reported More Shorted SharesBZ Weekly |